Document is current
Any future updates will be listed below
-
Authors
Locatelli, Franco
Buldini, Barbara
Pigazzi, Martina
Rizzari, Carmelo
Menna, Giuseppe
Fagioli, Franca
Tumino, Manuela
Lo Nigro, Luca
D’Angelo, Paolo
Cefalo, Maria Giuseppina
Paganelli, Valeria
Strocchio, Luisa
Becilli, Marco
Spinelli, Marco
Giagnuolo, Giovanna
Saglio, Francesco
Santoro, Nicola
Micalizzi, Concetta
Zecca, Marco
Masetti, Riccardo
Merli, Pietro
-
Funding
Funding for this research was provided by:
Fondazione Umberto Veronesi (PALM Research Project)
- License Information
-
More Information
Article History
Received: 8 February 2026
Accepted: 8 April 2026
First Online: 20 April 2026
Declarations
:
: The study was approved by the Ethical Committees of Bambino Gesù Children’s Hospital and thereafter by each participating center. Informed written consent was obtained before enrolment in accordance with regulatory guidelines. Written informed consent was obtained by both parents or legal representatives; minors above the age of 12 were required to provide written assent.
: Not applicable.
: FL is on the advisory board for Amgen, Novartis, Sanofi, Vertex; speaker’s bureau for Miltenyi Biomedicine, Amgen, Novartis, Bristol Myers Squibb, Gilead, SOBI. CR reports receipt of grants/research supports from SERB, honoraria or consultation fees from AMGEN, CLINIGEN, JAZZ, SERVIER, SERB, and speaker’s bureau for JAZZ. PM has received consulting fee from SOBI, Miltenyi, Amgen, and Pierre Fabre.
